Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ4	positive	NDUFS8	ENSG00000110717	COQ4	1	COQ4	1	0.00394304491443664	WBGene00020636	WBGene00020636(0)		Isolated complex I deficiency;Leigh syndrome with leukodystrophy;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I DEFICIENCY;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 2	GO:0016020;GO:0046872;GO:0016491;GO:0055114;GO:0005739;GO:0070469;GO:0051536;GO:0051539;GO:0009060;GO:0016651;GO:0032981;GO:0005759;GO:0003954;GO:0008137;GO:0005747;GO:0006120;GO:0006979	membrane;oxidation-reduction process;4 iron, 4 sulfur cluster binding;oxidoreductase activity, acting on NAD(P)H;metal ion binding;oxidoreductase activity;mitochondrion;iron-sulfur cluster binding;respirasome;protein binding;aerobic respiration;mitochondrial respiratory chain complex I assembly;mitochondrial matrix;NADH dehydrogenase activity;NADH dehydrogenase (ubiquinone) activity;mitochondrial respiratory chain complex I;mitochondrial electron transport, NADH to ubiquinone;response to oxidative stress	3D-structure;4Fe-4S;Disease mutation;Electron transport;Iron;Iron-sulfur;Metal-binding;Mitochondrion;NAD;Oxidoreductase;Primary mitochondrial disease;Reference proteome;Repeat;Respiratory chain;Transit peptide;Translocase;Transport;Ubiquinone	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ4	positive	NDUFB10	ENSG00000140990	COQ4	1	COQ4	1	0.00394304491443664	WBGene00010326	WBGene00010326(0)		Isolated complex I deficiency	GO:0016020;GO:0055114;GO:0005743;GO:0005739;GO:0005515;GO:0070469;GO:0032981;GO:0008137;GO:0005747;GO:0006120	membrane;oxidation-reduction process;mitochondrial inner membrane;mitochondrion;protein binding;respirasome;mitochondrial respiratory chain complex I assembly;NADH dehydrogenase (ubiquinone) activity;mitochondrial respiratory chain complex I;mitochondrial electron transport, NADH to ubiquinone	3D-structure;Alternative splicing;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Reference proteome;Respiratory chain;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ4	positive	NDUFB11	ENSG00000147123	COQ4	1	COQ4	1	0.00394304491443664	WBGene00018361	WBGene00018361(0)		Isolated complex I deficiency;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME;LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1;LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 30	GO:0016020;GO:0016021;GO:0055114;GO:0005739;GO:0005743;GO:0005515;GO:0070469;GO:0032981;GO:0005747;GO:0006120	membrane;integral component of membrane;oxidation-reduction process;mitochondrial inner membrane;mitochondrion;protein binding;respirasome;mitochondrial respiratory chain complex I assembly;mitochondrial respiratory chain complex I;mitochondrial electron transport, NADH to ubiquinone	3D-structure;Alternative splicing;Cardiomyopathy;Disease mutation;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ4	positive	MRPL55	ENSG00000162910	COQ4	1	COQ4	1	0.00394304491443664	WBGene00022045				GO:0003735;GO:0005840;GO:0005762;GO:0006412;GO:0005739;GO:0005743;GO:0070125;GO:0070126	structural constituent of ribosome;mitochondrial large ribosomal subunit;ribosome;translation;mitochondrion;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Alternative splicing;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ4	positive	PMVK	ENSG00000163344	COQ4	1	COQ4	1	0.00394304491443664	WBGene00009335	WBGene00009335(1)		Porokeratosis of Mibelli;POROKERATOSIS 1 MULTIPLE TYPES	GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0006629;GO:0005829;GO:0006694;GO:0008202;GO:0016126;GO:0008203;GO:0005777;GO:0006695;GO:0019287;GO:0070062;GO:0045540;GO:0070723;GO:0004631;GO:0008299	cytoplasm;phosphomevalonate kinase activity;cholesterol biosynthetic process;membrane;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;lipid metabolic process;cytosol;steroid biosynthetic process;steroid metabolic process;sterol biosynthetic process;cholesterol metabolic process;peroxisome;isopentenyl diphosphate biosynthetic process, mevalonate pathway;extracellular exosome;regulation of cholesterol biosynthetic process;response to cholesterol;isoprenoid biosynthetic process	3D-structure;ATP-binding;Cholesterol biosynthesis;Cholesterol metabolism;Cytoplasm;Disease mutation;Kinase;Lipid biosynthesis;Lipid metabolism;Nucleotide-binding;Polymorphism;Reference proteome;Steroid biosynthesis;Steroid metabolism;Sterol biosynthesis;Sterol metabolism;Transferase	R-HSA-1430728;R-HSA-556833;R-HSA-8957322;R-HSA-1655829;R-HSA-2426168;R-HSA-191273	Metabolism;Metabolism of lipids;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Activation of gene expression by SREBF (SREBP);Cholesterol biosynthesis
COQ4	positive	BCS1L	ENSG00000074582	COQ4	1	COQ4	1	0.00507308726833533	WBGene00010042	WBGene00010042(0)		Bjornstad syndrome;GRACILE SYNDROME;Isolated complex III deficiency;Renal tubulopathy-encephalopathy-liver failure syndrome;GRACILE SYNDROME;Bjornstad syndrome;GRACILE SYNDROME;Leigh syndrome;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 1	GO:0005739;GO:0016020;GO:0016021;GO:0034551;GO:0005524;GO:0000166;GO:0005743;GO:0005515;GO:0007005;GO:0032981;GO:0033617;GO:0005750	mitochondrial respiratory chain complex III assembly;mitochondrion;membrane;integral component of membrane;ATP binding;nucleotide binding;mitochondrial inner membrane;protein binding;mitochondrion organization;mitochondrial respiratory chain complex I assembly;mitochondrial respiratory chain complex IV assembly;mitochondrial respiratory chain complex III	ATP-binding;Chaperone;Deafness;Disease mutation;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
COQ4	positive	TXN2	ENSG00000100348	COQ4	1	COQ4	1	0.00507308726833533	WBGene00007099;WBGene00015062;WBGene00021548;WBGene00021933	WBGene00007099(1)		Combined oxidative phosphorylation defect type 29;Combined oxidative phosphorylation deficiency 29	GO:0005730;GO:0055114;GO:0005739;GO:0045454;GO:0005515;GO:0015035;GO:0005759;GO:0006662;GO:0000098;GO:0008113;GO:0033743;GO:0044877;GO:0001666;GO:0006979;GO:0009725;GO:0009749;GO:0014070;GO:0031669;GO:0042493;GO:0048678;GO:0030425;GO:0043025;GO:0005623	protein disulfide oxidoreductase activity;cell redox homeostasis;glycerol ether metabolic process;cell;nucleolus;oxidation-reduction process;mitochondrion;protein binding;mitochondrial matrix;sulfur amino acid catabolic process;peptide-methionine (S)-S-oxide reductase activity;peptide-methionine (R)-S-oxide reductase activity;protein-containing complex binding;response to hypoxia;response to oxidative stress;response to hormone;response to glucose;response to organic cyclic compound;cellular response to nutrient levels;response to drug;response to axon injury;dendrite;neuronal cell body	3D-structure;Acetylation;Direct protein sequencing;Disulfide bond;Electron transport;Mitochondrion;Neurodegeneration;Primary mitochondrial disease;Redox-active center;Reference proteome;Transit peptide;Transport	R-HSA-1430728;R-HSA-71291;R-HSA-2262752;R-HSA-8953897;R-HSA-3299685;R-HSA-1614558;R-HSA-1614635	Metabolism;Metabolism of amino acids and derivatives;Cellular responses to stress;Cellular responses to external stimuli;Detoxification of Reactive Oxygen Species;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism
COQ4	positive	ECSIT	ENSG00000130159	COQ4	1	COQ4	1	0.00507308726833533	WBGene00021202	WBGene00021202(0)			GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005739;GO:0055114;GO:0005515;GO:0002376;GO:0045087;GO:0032981;GO:0005743;GO:0016651;GO:0051341	nucleus;cytoplasm;nucleoplasm;cytosol;mitochondrion;protein binding;immune system process;innate immune response;regulation of protein complex stability;mitochondrial respiratory chain complex I assembly;mitochondrial inner membrane;regulation of oxidoreductase activity	Alternative splicing;Cytoplasm;Immunity;Innate immunity;Mitochondrion;Nucleus;Polymorphism;Reference proteome;Transit peptide	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-166016;R-HSA-166058;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-975138;R-HSA-975155;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198;R-HSA-168142;R-HSA-168176;R-HSA-975871	Innate Immune System;Immune System;Metabolism;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;MyD88 cascade initiated on plasma membrane
COQ4	positive	DCXR	ENSG00000169738	COQ4	1	COQ4	1	0.00507308726833533	WBGene00000984	WBGene00000984(1)		Pentosuria;Pentosuria	GO:0016491;GO:0055114;GO:0005634;GO:0016020;GO:0005975;GO:0005886;GO:0042802;GO:0006006;GO:0016614;GO:0050038;GO:0005997;GO:0006739;GO:0051289;GO:0005902;GO:0005903;GO:0070062;GO:0005881;GO:0019640;GO:0042732;GO:0016655;GO:0004090;GO:0044105	oxidoreductase activity;oxidation-reduction process;nucleus;membrane;carbohydrate metabolic process;plasma membrane;identical protein binding;glucose metabolic process;oxidoreductase activity, acting on CH-OH group of donors;L-xylulose reductase (NADP+) activity;xylulose metabolic process;NADP metabolic process;microvillus;brush border;extracellular exosome;cytoplasmic microtubule;glucuronate catabolic process to xylulose 5-phosphate;D-xylose metabolic process;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;carbonyl reductase (NADPH) activity;L-xylulose reductase (NAD+) activity	3D-structure;Acetylation;Carbohydrate metabolism;Direct protein sequencing;Glucose metabolism;Membrane;Methylation;NADP;Oxidoreductase;Phosphoprotein;Reference proteome;Xylose metabolism	R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-5668914;R-HSA-5663084;R-HSA-5661270;R-HSA-5662853	Metabolism;Disease;Metabolism of carbohydrates;Diseases of metabolism;Diseases of carbohydrate metabolism;Formation of xylulose-5-phosphate;Essential pentosuria
COQ4	positive	EDF1	ENSG00000107223	COQ4	1	COQ4	1	0.00648291474042617	WBGene00003148	WBGene00003148(1)			GO:0003723;GO:0005634;GO:0005737;GO:0005730;GO:0005829;GO:0003677;GO:0019216;GO:0005515;GO:0007275;GO:0030154;GO:0003713;GO:0045893;GO:0005516;GO:0005622;GO:0006355;GO:0045446;GO:0001094;GO:0043388;GO:0043565	DNA binding;RNA binding;nucleus;cytoplasm;nucleoplasm;nucleolus;cytosol;regulation of lipid metabolic process;protein binding;multicellular organism development;cell differentiation;transcription coactivator activity;positive regulation of transcription, DNA-templated;calmodulin binding;regulation of transcription, DNA-templated;intracellular;TFIID-class transcription factor complex binding;positive regulation of DNA binding;endothelial cell differentiation	3D-structure;Acetylation;Activator;Alternative splicing;Calmodulin-binding;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation		
COQ4	positive	MRPS26	ENSG00000125901	COQ4	1	COQ4	1	0.00648291474042617	WBGene00016412	WBGene00016412(0)			GO:0003723;GO:0005654;GO:0005739;GO:0005840;GO:0005763;GO:0005743;GO:0070125;GO:0070126;GO:0042769	mitochondrial small ribosomal subunit;RNA binding;nucleoplasm;mitochondrion;ribosome;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;DNA damage response, detection of DNA damage	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ4	positive	ELOF1	ENSG00000130165	COQ4	1	COQ4	1	0.00648291474042617	WBGene00013219	WBGene00013219(1)			GO:0005634;GO:0046872;GO:0003746;GO:0006414;GO:0005515;GO:0006368;GO:0000993;GO:0008023;GO:0048096	nucleus;metal ion binding;translation elongation factor activity;translational elongation;protein binding;transcription elongation from RNA polymerase II promoter;RNA polymerase II complex binding;transcription elongation factor complex;chromatin-mediated maintenance of transcription	Metal-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ4	positive	PPAN	ENSG00000130810	COQ4	1	COQ4	1	0.00648291474042617	WBGene00003062	WBGene00003062(1)			GO:0003723;GO:0005634;GO:0005730;GO:0000027;GO:0030687	RNA binding;nucleus;nucleolus;rRNA binding;ribosomal large subunit assembly;preribosome, large subunit precursor	Acetylation;Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ4	positive	NDUFA2	ENSG00000131495	COQ4	1	COQ4	1	0.00648291474042617	WBGene00013406	WBGene00013406(0)		Cystic leukoencephalopathy without megalencephaly;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 13	GO:0016020;GO:0055114;GO:0005743;GO:0005739;GO:0070469;GO:0031966;GO:0032981;GO:0008137;GO:0005747;GO:0006120;GO:0001835	membrane;oxidation-reduction process;mitochondrial inner membrane;mitochondrion;respirasome;mitochondrial membrane;mitochondrial respiratory chain complex I assembly;NADH dehydrogenase (ubiquinone) activity;mitochondrial respiratory chain complex I;mitochondrial electron transport, NADH to ubiquinone;blastocyst hatching	3D-structure;Acetylation;Alternative splicing;Disulfide bond;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ4	positive	SURF1	ENSG00000148290	COQ4	1	COQ4	1	0.00648291474042617	WBGene00004787	WBGene00004787(1)		Leigh syndrome with cardiomyopathy;Leigh syndrome with leukodystrophy;SURF1-related Charcot-Marie-Tooth disease type 4;Complex IV deficiency;Leigh syndrome;CHARCOT-MARIE-TOOTH DISEASE TYPE 4K;Leigh syndrome	GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0005515;GO:1902600;GO:0022900;GO:0004129;GO:0033617;GO:0006119;GO:0009060;GO:0055114;GO:0005746;GO:0008535	membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;protein binding;proton transmembrane transport;electron transport chain;cytochrome-c oxidase activity;mitochondrial respiratory chain complex IV assembly;oxidative phosphorylation;aerobic respiration;oxidation-reduction process;mitochondrial respirasome;respiratory chain complex IV assembly	Alternative splicing;Charcot-Marie-Tooth disease;Disease mutation;Leigh syndrome;Membrane;Mitochondrion;Mitochondrion inner membrane;Neurodegeneration;Neuropathy;Polymorphism;Primary mitochondrial disease;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-5628897	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;TP53 Regulates Metabolic Genes
COQ4	positive	MFSD3	ENSG00000167700	COQ4	1	COQ4	1	0.00648291474042617					GO:0016020;GO:0016021;GO:0055085;GO:0005887;GO:1902600;GO:0015295	membrane;transmembrane transport;integral component of membrane;proton transmembrane transport;solute:proton symporter activity	Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ4	positive	ATP5ME	ENSG00000169020	COQ4	1	COQ4	1	0.00648291474042617		WBGene00011015(0)			GO:0016020;GO:0005739;GO:0005743;GO:0006811;GO:0015078;GO:0015986;GO:0000276;GO:0016887;GO:0006754;GO:0022857;GO:0042407;GO:0042776;GO:0005753;GO:0045263;GO:0044877;GO:0046034	ATP synthesis coupled proton transport;proton transmembrane transporter activity;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);membrane;mitochondrion;mitochondrial inner membrane;ion transport;ATP biosynthetic process;proton-transporting ATP synthase activity, rotational mechanism;cristae formation;mitochondrial ATP synthesis coupled proton transport;mitochondrial proton-transporting ATP synthase complex;proton-transporting ATP synthase complex, coupling factor F(o);protein-containing complex binding;ATP metabolic process	ATP synthesis;Acetylation;CF(0);Direct protein sequencing;Hydrogen ion transport;Ion transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Reference proteome;Transport	R-HSA-1852241;R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-1592230;R-HSA-8949613;R-HSA-163210	Organelle biogenesis and maintenance;Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial biogenesis;Cristae formation;Formation of ATP by chemiosmotic coupling
COQ4	positive	NDUFA3	ENSG00000170906	COQ4	1	COQ4	1	0.00648291474042617					GO:0005743;GO:0005747;GO:0016020;GO:0016021;GO:0055114;GO:0005739;GO:0070469;GO:0032981;GO:0008137;GO:0006120	mitochondrial inner membrane;mitochondrial respiratory chain complex I;membrane;integral component of membrane;oxidation-reduction process;mitochondrion;respirasome;mitochondrial respiratory chain complex I assembly;NADH dehydrogenase (ubiquinone) activity;mitochondrial electron transport, NADH to ubiquinone	3D-structure;Acetylation;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ4	positive	GATD1	ENSG00000177225	COQ4	1	COQ4	1	0.00648291474042617					GO:0005576;GO:0070062;GO:0003674;GO:0008150	extracellular region;extracellular exosome;molecular_function;biological_process	Alternative splicing;Glycoprotein;Reference proteome;Secreted;Signal		
COQ4	positive	EIF3K	ENSG00000178982	COQ4	1	COQ4	1	0.00648291474042617	WBGene00001233	WBGene00001233(1)			GO:0005737;GO:0003743;GO:0006412;GO:0006413;GO:0005852;GO:0005829;GO:0043022;GO:0006446;GO:0003723;GO:0005634;GO:0016020;GO:0001732;GO:0002183;GO:0016282;GO:0033290;GO:0005515	cytoplasm;translation initiation factor activity;ribosome binding;eukaryotic translation initiation factor 3 complex;regulation of translational initiation;translation;translational initiation;cytosol;RNA binding;nucleus;membrane;formation of cytoplasmic translation initiation complex;cytoplasmic translational initiation;eukaryotic 43S preinitiation complex;eukaryotic 48S preinitiation complex;protein binding	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Initiation factor;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome	R-HSA-392499;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72689;R-HSA-72695;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766	Metabolism of proteins;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
COQ4	positive	MRPL40	ENSG00000185608	COQ4	1	COQ4	1	0.00648291474042617	WBGene00018793	WBGene00018793(1)			GO:0003723;GO:0005739;GO:0005840;GO:0005515;GO:0005762;GO:0005634;GO:0009653;GO:0005743;GO:0070125;GO:0070126;GO:0005761	mitochondrial large ribosomal subunit;RNA binding;nucleolus;mitochondrion;ribosome;protein binding;nucleus;anatomical structure morphogenesis;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome	3D-structure;Mitochondrion;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ4	positive	C8orf82	ENSG00000213563	COQ4	1	COQ4	1	0.00648291474042617	WBGene00044251	WBGene00044251(1)					Alternative splicing;Reference proteome		
COQ4	positive	NDUFS3	ENSG00000213619	COQ4	1	COQ4	1	0.00648291474042617	WBGene00020417	WBGene00020417(1)		Isolated complex I deficiency;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 8	GO:0016020;GO:0016491;GO:0055114;GO:0005739;GO:0005743;GO:0005515;GO:0016604;GO:0070469;GO:0008137;GO:0031966;GO:0016651;GO:0005759;GO:0003954;GO:0021762;GO:0005747;GO:0030308;GO:0006120;GO:0032981;GO:2001243;GO:0009055;GO:0072593	oxidation-reduction process;NADH dehydrogenase (ubiquinone) activity;oxidoreductase activity, acting on NAD(P)H;membrane;oxidoreductase activity;mitochondrion;mitochondrial inner membrane;protein binding;nuclear body;respirasome;mitochondrial membrane;mitochondrial matrix;NADH dehydrogenase activity;substantia nigra development;mitochondrial respiratory chain complex I;negative regulation of cell growth;mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly;negative regulation of intrinsic apoptotic signaling pathway;electron transfer activity;reactive oxygen species metabolic process	3D-structure;Alternative splicing;Direct protein sequencing;Disease mutation;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;NAD;Oxidoreductase;Polymorphism;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transit peptide;Translocase;Transport;Ubiquinone	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ4	positive	TLE2	ENSG00000065717	COQ4	1	COQ4	1	0.00822881575524492	WBGene00006773				GO:0005634;GO:0006355;GO:0005925;GO:0005615;GO:0005515;GO:0016604;GO:0016055;GO:0003714;GO:0070491;GO:0090090;GO:0005667;GO:0005654;GO:0007165;GO:0045892;GO:1904837;GO:0009887	regulation of transcription, DNA-templated;nucleus;protein binding;nucleoplasm;focal adhesion;extracellular space;nuclear body;Wnt signaling pathway;transcription corepressor activity;repressing transcription factor binding;negative regulation of canonical Wnt signaling pathway;transcription factor complex;signal transduction;negative regulation of transcription, DNA-templated;beta-catenin-TCF complex assembly;animal organ morphogenesis	Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;WD repeat;Wnt signaling pathway	R-HSA-162582;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-157118;R-HSA-1980143;R-HSA-201722;R-HSA-3769402;R-HSA-2122947;R-HSA-4641265	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Signaling by NOTCH;Signaling by NOTCH1;Formation of the beta-catenin:TCF transactivating complex;Deactivation of the beta-catenin transactivating complex;NOTCH1 Intracellular Domain Regulates Transcription;Repression of WNT target genes
COQ4	positive	MRPS34	ENSG00000074071	COQ4	1	COQ4	1	0.00822881575524492	WBGene00010905	WBGene00010905(0)		Leigh Syndrome with Instability of the Small Mitoribosomal Subunit;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32	GO:0005739;GO:0003735;GO:0032543;GO:0005840;GO:0005763;GO:0005743;GO:0070125;GO:0070126	structural constituent of ribosome;mitochondrion;mitochondrial translation;ribosome;mitochondrial small ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Disease mutation;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Ribonucleoprotein;Ribosomal protein	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ4	positive	ATP5F1D	ENSG00000099624	COQ4	1	COQ4	1	0.00822881575524492	WBGene00019061	WBGene00019061(1)		Isolated ATP synthase deficiency;ATP5F1D metabolic disorder;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY NUCLEAR TYPE 5	GO:0016020;GO:0005524;GO:0005743;GO:0005739;GO:0006811;GO:0005515;GO:0046933;GO:0015986;GO:0045261;GO:0005759;GO:0016887;GO:0006754;GO:0022857;GO:0042407;GO:0042776;GO:0005753;GO:0006119;GO:0046688;GO:0043531;GO:0009060;GO:0033615;GO:0000275	proton-transporting ATP synthase activity, rotational mechanism;ATP synthesis coupled proton transport;proton-transporting ATP synthase complex, catalytic core F(1);membrane;ATP binding;mitochondrial inner membrane;mitochondrion;ion transport;protein binding;ATPase activity;mitochondrial matrix;ATP biosynthetic process;cristae formation;mitochondrial ATP synthesis coupled proton transport;mitochondrial proton-transporting ATP synthase complex;oxidative phosphorylation;response to copper ion;ADP binding;aerobic respiration;mitochondrial proton-transporting ATP synthase complex assembly;mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)	ATP synthesis;Acetylation;CF(1);Direct protein sequencing;Disease mutation;Hydrogen ion transport;Ion transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Primary mitochondrial disease;Reference proteome;Transit peptide;Transport	R-HSA-1852241;R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-1592230;R-HSA-8949613;R-HSA-163210	Organelle biogenesis and maintenance;Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial biogenesis;Cristae formation;Formation of ATP by chemiosmotic coupling
COQ4	positive	PQBP1	ENSG00000102103	COQ4	1	COQ4	1	0.00822881575524492	WBGene00020647;WBGene00020295	WBGene00020647(1)		Hamel cerebro-palato-cardiac syndrome;X-linked intellectual disability Golabi-Ito-Hall type;X-linked intellectual disability Porteous type;X-linked intellectual disability Sutherland-Haan type;RENPENNING SYNDROME 1;RENPENNING SYNDROME 1	GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0005829;GO:1903508;GO:0005515;GO:0002376;GO:0045087;GO:0051607;GO:0000380;GO:0031175;GO:0048814;GO:0005737;GO:0010494;GO:0071598;GO:0005654;GO:0003690;GO:0003677;GO:0003713;GO:0002218;GO:0002230;GO:0006355;GO:0000398;GO:0043021;GO:0032481;GO:0043484;GO:0071360	protein binding;mRNA processing;RNA splicing;nucleus;nuclear speck;cytosol;positive regulation of nucleic acid-templated transcription;immune system process;innate immune response;defense response to virus;alternative mRNA splicing, via spliceosome;neuron projection development;regulation of dendrite morphogenesis;cytoplasm;cytoplasmic stress granule;neuronal ribonucleoprotein granule;nucleoplasm;double-stranded DNA binding;DNA binding;transcription coactivator activity;activation of innate immune response;positive regulation of defense response to virus by host;regulation of transcription, DNA-templated;mRNA splicing, via spliceosome;ribonucleoprotein complex binding;positive regulation of type I interferon production;regulation of RNA splicing;cellular response to exogenous dsRNA	3D-structure;Alternative splicing;Direct protein sequencing;Immunity;Innate immunity;Mental retardation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
COQ4	positive	POLR2I	ENSG00000105258	COQ4	1	COQ4	1	0.00822881575524492	WBGene00022400	WBGene00022400(0)			GO:0003676;GO:0005634;GO:0008270;GO:0046872;GO:0005654;GO:0006351;GO:0006379;GO:0005730;GO:0003899;GO:0006366;GO:0060964;GO:0006368;GO:0006370;GO:0050434;GO:0006367;GO:0042795;GO:0000398;GO:0006283;GO:0008543;GO:0016070;GO:0035019;GO:0005665;GO:0001193	zinc ion binding;transcription, DNA-templated;nucleic acid binding;mRNA cleavage;nucleus;metal ion binding;nucleoplasm;nucleolus;DNA-directed 5'-3' RNA polymerase activity;transcription by RNA polymerase II;regulation of gene silencing by miRNA;transcription elongation from RNA polymerase II promoter;7-methylguanosine mRNA capping;positive regulation of viral transcription;transcription initiation from RNA polymerase II promoter;snRNA transcription by RNA polymerase II;mRNA splicing, via spliceosome;transcription-coupled nucleotide-excision repair;fibroblast growth factor receptor signaling pathway;RNA metabolic process;somatic stem cell population maintenance;RNA polymerase II, core complex;maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter	3D-structure;Acetylation;DNA-directed RNA polymerase;Metal-binding;Nucleus;Reference proteome;Transcription;Zinc;Zinc-finger	R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-8953854;R-HSA-1643685;R-HSA-73894;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-5663202;R-HSA-112382;R-HSA-167152;R-HSA-167169;R-HSA-167172;R-HSA-167200;R-HSA-167238;R-HSA-167243;R-HSA-167246;R-HSA-167287;R-HSA-167290;R-HSA-674695;R-HSA-6796648;R-HSA-75955;R-HSA-9006934;R-HSA-168254;R-HSA-168255;R-HSA-168273;R-HSA-168325;R-HSA-211000;R-HSA-5578749;R-HSA-72203;R-HSA-8939211;R-HSA-9006931;R-HSA-113418;R-HSA-167158;R-HSA-167160;R-HSA-167242;R-HSA-6807505;R-HSA-72086;R-HSA-77075;R-HSA-167161;R-HSA-167162;R-HSA-73776;R-HSA-73779;R-HSA-75953;R-HSA-76042;R-HSA-5617472;R-HSA-5619507;R-HSA-9018519;R-HSA-72163;R-HSA-72172;R-HSA-1226099;R-HSA-1839126;R-HSA-190236;R-HSA-203927;R-HSA-5601884;R-HSA-5654738;R-HSA-5655253;R-HSA-5696398;R-HSA-6781823;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-6803529;R-HSA-72165;R-HSA-8851708	Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Metabolism of RNA;Disease;DNA Repair;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Diseases of signal transduction;Formation of RNA Pol II elongation complex ;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription Elongation;Signaling by Receptor Tyrosine Kinases;Influenza Infection;Influenza Life Cycle;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;Gene Silencing by RNA;Transcriptional regulation by small RNAs;Processing of Capped Intron-Containing Pre-mRNA;ESR-mediated signaling;Signaling by Nuclear Receptors;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;Abortive elongation of HIV-1 transcript in the absence of Tat;RNA polymerase II transcribes snRNA genes;mRNA Capping;RNA Pol II CTD phosphorylation and interaction with CE;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Estrogen-dependent gene expression;mRNA Splicing - Major Pathway;mRNA Splicing;Signaling by FGFR in disease;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;PIWI-interacting RNA (piRNA) biogenesis;Signaling by FGFR2;Signaling by FGFR2 in disease;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;FGFR2 alternative splicing;mRNA Splicing - Minor Pathway;Signaling by FGFR2 IIIa TM
COQ4	positive	SLC6A8	ENSG00000130821	COQ4	1	COQ4	1	0.00822881575524492	WBGene00004900;WBGene00004901;WBGene00004902;WBGene00004904;WBGene00004905;WBGene00004906;WBGene00004908;WBGene00004911;WBGene00012787;WBGene00004910			X-linked creatine transporter deficiency;X-LINKED CREATINE DEFICIENCY SYNDROME;CEREBRAL CREATINE DEFICIENCY SYNDROME 1	GO:0016020;GO:0016021;GO:0005887;GO:0015293;GO:0006811;GO:0006814;GO:0005328;GO:0006836;GO:0055085;GO:0005886;GO:0043005;GO:0015812;GO:0003674;GO:0006936;GO:0006600;GO:0005332;GO:0042165;GO:0005308;GO:0005309;GO:0015881	integral component of membrane;membrane;integral component of plasma membrane;neurotransmitter transport;neurotransmitter:sodium symporter activity;creatine:sodium symporter activity;symporter activity;ion transport;sodium ion transport;transmembrane transport;plasma membrane;neuron projection;gamma-aminobutyric acid transport;molecular_function;muscle contraction;creatine metabolic process;gamma-aminobutyric acid:sodium symporter activity;neurotransmitter binding;creatine transmembrane transporter activity;creatine transmembrane transport	Alternative splicing;Disease mutation;Glycoprotein;Ion transport;Membrane;Mental retardation;Phosphoprotein;Polymorphism;Reference proteome;Sodium;Sodium transport;Symport;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-71291;R-HSA-71288	Metabolism;Metabolism of amino acids and derivatives;Creatine metabolism
COQ4	positive	SUCLG1	ENSG00000163541	COQ4	1	COQ4	1	0.00822881575524492	WBGene00007350;WBGene00017759	WBGene00017759(1);WBGene00007350(1)		Fatal infantile lactic acidosis with methylmalonic aciduria;Fatal Infantile Lactic Acidosis;MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	GO:0003723;GO:0000166;GO:0005829;GO:0006099;GO:0005739;GO:0003824;GO:0005886;GO:0016874;GO:0048037;GO:0004774;GO:0004775;GO:0004776;GO:0006165;GO:0005759;GO:0004550;GO:0006104;GO:0006105;GO:0009142	catalytic activity;cofactor binding;RNA binding;nucleotide binding;cytosol;plasma membrane;tricarboxylic acid cycle;mitochondrion;ligase activity;nucleoside diphosphate phosphorylation;succinate-CoA ligase (ADP-forming) activity;mitochondrial matrix;nucleoside diphosphate kinase activity;succinate-CoA ligase activity;succinate-CoA ligase (GDP-forming) activity;succinyl-CoA metabolic process;succinate metabolic process;nucleoside triphosphate biosynthetic process	3D-structure;Acetylation;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Polymorphism;Primary mitochondrial disease;Reference proteome;Transit peptide;Tricarboxylic acid cycle	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
COQ4	positive	MON1A	ENSG00000164077	COQ4	1	COQ4	1	0.00822881575524492	WBGene00018321	WBGene00018321(0)			GO:0005085;GO:0006623;GO:0005515;GO:0005829;GO:0009306;GO:0035658;GO:0005623	protein targeting to vacuole;guanyl-nucleotide exchange factor activity;protein binding;cytosol;protein secretion;Mon1-Ccz1 complex	Alternative splicing;Guanine-nucleotide releasing factor;Phosphoprotein;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-8876198;R-HSA-9007101	Vesicle-mediated transport;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
COQ4	positive	SPACA9	ENSG00000165698	COQ4	1	COQ4	1	0.00822881575524492					GO:0005634;GO:0005737;GO:0031514;GO:0005856;GO:0042995;GO:0005515;GO:0031410;GO:0048306;GO:0001669;GO:0036064;GO:0005929;GO:0097546;GO:0005881;GO:0036126	nucleus;cytoplasm;motile cilium;cytoskeleton;cell projection;protein binding;cytoplasmic vesicle;calcium-dependent protein binding;acrosomal vesicle;ciliary basal body;sperm flagellum;ciliary base;cilium;cytoplasmic microtubule	Alternative splicing;Cell projection;Cilium;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Flagellum;Nucleus;Polymorphism;Reference proteome		
COQ4	positive	ELP5	ENSG00000170291	COQ4	1	COQ4	1	0.00822881575524492					GO:0005829;GO:0002098;GO:0033588;GO:0005634;GO:0005737;GO:0008033;GO:0005515;GO:0030335	tRNA wobble uridine modification;Elongator holoenzyme complex;nucleoplasm;cytosol;nucleus;cytoplasm;tRNA processing;protein binding;positive regulation of cell migration	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;tRNA processing	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ4	positive	CCS	ENSG00000173992	COQ4	1	COQ4	1	0.00822881575524492	WBGene00004930;WBGene00007036				GO:0005634;GO:0005737;GO:0046872;GO:0055114;GO:0005515;GO:0030001;GO:0005507;GO:0006801;GO:0005829;GO:0045296;GO:0015035;GO:0016532;GO:0015680;GO:0019430;GO:0034599;GO:0051353;GO:0004784	metal ion binding;oxidation-reduction process;metal ion transport;superoxide dismutase activity;superoxide metabolic process;nucleus;cytoplasm;protein binding;copper ion binding;cytosol;cadherin binding;protein disulfide oxidoreductase activity;superoxide dismutase copper chaperone activity;protein maturation by copper ion transfer;removal of superoxide radicals;cellular response to oxidative stress;positive regulation of oxidoreductase activity	3D-structure;Chaperone;Copper;Cytoplasm;Disulfide bond;Isopeptide bond;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc	R-HSA-2262752;R-HSA-8953897;R-HSA-3299685	Cellular responses to stress;Cellular responses to external stimuli;Detoxification of Reactive Oxygen Species
COQ4	positive	CHID1	ENSG00000177830	COQ4	1	COQ4	1	0.00822881575524492	WBGene00016642;WBGene00019980	WBGene00019980(0)			GO:0005975;GO:0005634;GO:0016020;GO:0005615;GO:0005576;GO:0008061;GO:0002376;GO:0045087;GO:0005764;GO:0005515;GO:0070062;GO:0005802;GO:0005770;GO:0002576;GO:0043202;GO:1900016;GO:0070492	carbohydrate metabolic process;chitin binding;nucleus;membrane;extracellular space;extracellular region;immune system process;innate immune response;lysosome;protein binding;extracellular exosome;trans-Golgi network;late endosome;platelet degranulation;lysosomal lumen;negative regulation of cytokine production involved in inflammatory response;oligosaccharide binding	3D-structure;Alternative splicing;Immunity;Innate immunity;Lysosome;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-109582;R-HSA-76002;R-HSA-76005;R-HSA-114608	Hemostasis;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation 
COQ4	positive	MRPL54	ENSG00000183617	COQ4	1	COQ4	1	0.00822881575524492	WBGene00009128	WBGene00009128(1)			GO:0003723;GO:0005739;GO:0005840;GO:0003735;GO:0005762;GO:0005743;GO:0070125;GO:0070126	RNA binding;mitochondrion;ribosome;structural constituent of ribosome;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ4	positive	THAP7	ENSG00000184436	COQ4	1	COQ4	1	0.00822881575524492					GO:0003676;GO:0005634;GO:0016607;GO:0043231;GO:0046872;GO:0003677;GO:0031965;GO:0005694;GO:0005515;GO:0042802;GO:0006357;GO:0000981;GO:0000790;GO:0045892;GO:0047485;GO:0070742	nucleic acid binding;nucleus;nuclear speck;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;DNA binding;nuclear membrane;chromosome;protein binding;identical protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;negative regulation of transcription, DNA-templated;protein N-terminus binding;C2H2 zinc finger domain binding	Chromosome;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ4	negative	RAB8B	ENSG00000166128	COQ4	1	COQ4	1	0.00411086081234013	WBGene00004272;WBGene00004273	WBGene00004272(1)			GO:0016020;GO:0015031;GO:0043231;GO:0000166;GO:0005654;GO:0003924;GO:0005525;GO:0005886;GO:0016604;GO:0031410;GO:0005778;GO:0006886;GO:0005515;GO:0070062;GO:0030670;GO:0032482;GO:0009306;GO:0005768;GO:0008021;GO:0005102;GO:0019003;GO:0072659;GO:0017157;GO:0030140;GO:0045335;GO:0006904;GO:0019882;GO:0055038;GO:0034332;GO:0032869;GO:0045046;GO:0048210;GO:0030911;GO:0031346;GO:0051461;GO:0048471;GO:0051286;GO:0098793	GTP binding;GTPase activity;membrane;protein transport;intracellular membrane-bounded organelle;nucleotide binding;nucleoplasm;plasma membrane;nuclear body;cytoplasmic vesicle;peroxisomal membrane;protein binding;intracellular protein transport;extracellular exosome;phagocytic vesicle membrane;Rab protein signal transduction;endomembrane system;protein secretion;endosome;synaptic vesicle;signaling receptor binding;GDP binding;protein localization to plasma membrane;regulation of exocytosis;trans-Golgi network transport vesicle;phagocytic vesicle;vesicle docking involved in exocytosis;antigen processing and presentation;recycling endosome membrane;cellular response to insulin stimulus;protein import into peroxisome membrane;Golgi vesicle fusion to target membrane;TPR domain binding;positive regulation of cell projection organization;positive regulation of corticotropin secretion;cell-substrate junction organization;perinuclear region of cytoplasm;cell tip;presynapse	Cell membrane;Cytoplasmic vesicle;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-8873719;R-HSA-8854214	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;RAB geranylgeranylation;TBC/RABGAPs
COQ4	negative	DSE	ENSG00000111817	COQ4	1	COQ4	1	0.00680655398824404				Musculocontractural Ehlers-Danlos syndrome;Ehlers-Danlos syndrome musculocontractural type 2;EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE 2	GO:0016020;GO:0016021;GO:0016853;GO:0005829;GO:0005654;GO:0000139;GO:0030208;GO:0005783;GO:0005794;GO:0015012;GO:0030206;GO:0047757	membrane;integral component of membrane;isomerase activity;nucleoplasm;cytosol;Golgi membrane;dermatan sulfate biosynthetic process;endoplasmic reticulum;Golgi apparatus;heparan sulfate proteoglycan biosynthetic process;chondroitin sulfate biosynthetic process;chondroitin-glucuronate 5-epimerase activity;chondroitin sulfate metabolic process;dermatan sulfate metabolic process	3D-structure;Disease mutation;Ehlers-Danlos syndrome;Glycoprotein;Isomerase;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71387;R-HSA-1630316;R-HSA-1793185;R-HSA-2022923	Metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Dermatan sulfate biosynthesis
